News
Psoriasis Treatment May Decrease Infection, Death Risk in End-Stage Kidney Disease
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
Hemoglobin levels lower, erythropoietin stimulating agent use higher, even for water lead levels below EPA threshold for regulatory action
Regular users may be at risk for serous retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy
Risk for hip fracture increased with EPO doses of 50 to 149, 150 to 299, and 300 or greater vs <50 units/kg/week